Johnson & Johnson (JNJ) Shares Bought by Dempze Nancy E

Henrietta Strickland
May 16, 2018

Brandywine Global Investment Management Llc who had been investing in Seacor Holdings Inc for a number of months, seems to be less bullish one the $950.71M market cap company. Boston Partners now owns 12,783,909 shares of the company's stock worth $1,638,258,000 after purchasing an additional 5,207,124 shares during the last quarter. Benedict Financial Advisors Inc owns 52,598 shares.

More notable recent Johnson & Johnson (NYSE:JNJ) news were published by: Benzinga.com which released: "Analyst: Morphosys Is Well-Positioned To Continue Success With Antibody Discovery Platforms" on May 14, 2018, also Livetradingnews.com with their article: "Johnson & Johnson (NYSE:JNJ) Heffx Technical Analysis" published on April 30, 2018, Seekingalpha.com published: "Novartis to initiate head-to-head study of Cosentyx versus J&J's Tremfya in patients with psoriatic plaques resistant to ..." on May 15, 2018. It has outperformed by 15.43% the S&P500.

Next Financial Group Inc decreased Johnson & Johnson (JNJ) stake by 28.4% reported in 2017Q4 SEC filing. The De Burlo Group Inc holds 62,950 shares with $8.80M value, up from 44,050 last quarter. Wellington Shields Capital Management Llc who had been investing in Johnson & Johnson for a number of months, seems to be bullish on the $339.13 billion market cap company. (NYSE:LB) went up during the trading session by $0.9 on Monday, trading at $33.23.

Johnson & Johnson (JNJ) finalized the Monday at price of $126.06 after traded 6090129 shares. JNJ is reaching $127.24 during the last trading session, after increased 1.51%.Currently Johnson & Johnson is uptrending after 1.12% change in last May 14, 2017. It has underperformed by 10.43% the S&P500.

Investors sentiment increased to 0.87 in 2017 Q4. Its up 0.21, from 1.07 in 2017Q3.

Sell-side analyst recommendations point to a short term price target of $143.68 on the shares of Johnson & Johnson (JNJ). Legal And General Gru Public Ltd Limited Liability Company has invested 0% in Libbey Inc. The company reported $2.06 earnings per share for the quarter, topping the consensus estimate of $2.00 by $0.06. Duff & Phelps Mngmt Communications, Illinois-based fund reported 29,645 shares. Funds hold 1.72 billion shares thus 0.40% more from 2017Q3's 1.71 billion shares. Franklin Res, a California-based fund reported 336,246 shares. Vantage Invest Limited Company stated it has 2.59% in Johnson & Johnson (NYSE:JNJ). Thomaspartners Incorporated has invested 3.1% in Johnson & Johnson (NYSE:JNJ).

In the transaction dated March 03, 2017, the great number of shares disposed came courtesy the Exec VP, WW Chair, Pharma; Duato Joaquin disposed a total of 50,000 shares at an average price of $123.62, amounting to approximately $6,181,000. Bartlett Ltd Com accumulated 196,715 shares or 1.09% of the stock. Washington Management has invested 0.31% in Johnson & Johnson (NYSE:JNJ). Capital Counsel Limited Liability Corporation New York has 442,043 shares for 5.08% of their portfolio. Stevens First Principles Advsrs reported 0.01% stake.

Since February 15, 2018, it had 0 insider buys, and 1 insider sale for $20.17 million activity.

Trb Advisors Lp, which manages about $140.60 million US Long portfolio, decreased its stake in Apple Inc (NASDAQ:AAPL) by 45,000 shares to 45,000 shares, valued at $7.62 million in 2017Q4, according to the filing. It also reduced its holding in Msci Inc Com (NYSE:MSCI) by 92,469 shares in the quarter, leaving it with 424,978 shares, and cut its stake in Csx Corp Com (NYSE:CSX).

Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 11 have Buy rating, 5 Sell and 7 Hold. Therefore 60% are positive. Stifel Nicolaus boosted their price objective on Johnson & Johnson from $142.00 to $145.00 and gave the stock a hold rating in a research report on Wednesday, January 24th. On Friday, January 12 the rating was maintained by Wells Fargo with "Buy". Jefferies maintained Johnson & Johnson (NYSE:JNJ) rating on Tuesday, June 14. Lord Abbett & Company bought 39,110 shares as the company's stock declined 9.21% with the market. Finally, Leerink Swann reissued an "outperform" rating and issued a $160.00 price objective (down from $175.00) on shares of Johnson & Johnson in a research note on Wednesday, April 18th. The rating was maintained by Deutsche Bank on Wednesday, April 18 with "Buy". The company was maintained on Friday, April 13 by Jefferies. The firm has "Neutral" rating given on Tuesday, January 2 by JP Morgan. The firm has "Buy" rating by Jefferies given on Monday, February 26. As per Wednesday, April 18, the company rating was maintained by Wells Fargo. (NYSE:CKH) were recently published by: Globenewswire.com, which released: "SEACOR Holdings Announces Signing of Exchange Agreement" on May 09, 2018. The ratio increased, as 36 institutional investors increased and started new holdings, while 17 trimmed and sold stakes in Prudential Global Short Duration High Yield Fund Inc. 7,212 are owned by Tradewinds Cap Ltd Limited Liability Company. Blue Chip invested 2.85% in Johnson & Johnson (NYSE:JNJ). Therefore 93% are positive. Facebook had 269 analyst reports since July 21, 2015 according to SRatingsIntel. (TSE:SJ) rating on Monday, August 10. (NASDAQ:FB) on Thursday, April 26 with "Overweight" rating. The company was maintained on Friday, August 12 by Scotia Capital. Credit Suisse maintained it with "Buy" rating and $154.0 target in Thursday, October 19 report.

Other reports by Click Lancashire

Discuss This Article

FOLLOW OUR NEWSPAPER